Here are relevant reports on : radiopharmaceuticals-market
-
European Nuclear Medicine/Radiopharmaceuticals Market by Type (Diagnostic (SPECT - Technetium, PET - F-18), Therapeutic (Beta Emitters - I-131, Alpha Emitters, Brachytherapy - Y-90)), Application (Oncology, Thyroid, Cardiology), Procedures - Forecasts to 2020
Over the years, the European nuclear medicine/radiopharmaceuticals market has witnessed various advancements in radiopharmaceuticals. The European radiopharmaceuticals market is witnessing growth owing to an increasing number of radioisotope approvals for different clinical indications. Tc-99m and F-18 radioisotopes are estimated to contribute the highest to the European nuclear medicine diagnostic market in 2015, whereas Ra-223, I-131 and Y-90 ensured their leading position in the therapeutic market. The European nuclear medicine/radiopharmaceuticals market is expected to reach $1.62 Billion by 2020 from $1.09 Billion in 2015, growing at a CAGR of 8.2% from 2015 to 2020.
- Published: November 2015
- Price: $ 4950
- TOC Available:
-
Asia-Pacific Nuclear Medicine/Radiopharmaceuticals & Stable Isotopes Market [SPECT/PET Radioisotopes (Technetium, F-18)], [Beta/Alpha Radiation Therapy (I131, Y-90)], [Applications (Cancer/Oncology, Cardiac)] & (Deuterium, C-13) – Forecast to 2017
The market is broadly classified into two segments, namely, diagnostic and therapeutic; the former dominated with about 80.7% share in 2012. Radioisotopes in the diagnostic market are categorized as SPECT and PET. Technetium 99m (Tc-99m) dominated the SPECT radioisotope market in 2012, followed by thallium–201(Tl-201), gallium–67 (Ga-67), and iodine-123 (I-123). SPECT is majorly used in cardiology-related diagnosis; it is poised to grow at a CAGR of 10.2% from 2012 to 2017. The radiopharmaceuticals market in the Asia-Pacific region was valued at $500.8 million in 2012; it is poised to reach $824.9million in 2017 at a CAGR of 10.5%.
- Published: May 2013
- Price: $ 4950
- TOC Available:
-
Theranostics Market by Product (Diagnostic imaging (PET, CT, MRI), Radiopharmaceuticals (Lu-177, Sm-153, Ra-223, I-131), Biomarker screening, Software), Application (Prostate Cancer, Bone metastasis), & Stakeholder Expectations - Global Forecast to 2028
The global theranostics market, valued at US$1.9 billion in 2022, stood at US$2.1 billion in 2023 and is projected to advance at a resilient CAGR of 15.5% from 2023 to 2028, culminating in a forecasted valuation of US$4.3 billion by the end of the period. Increasing establishment of hospitals, rising focus on targeted therapies, and introduction of novel theranostic approaches are expected to drive the market during the forecast period.
- Published: January 2024
- Price: $ 4950
- TOC Available:
-
North American Nuclear Medicine Market / Radiopharmaceuticals Market Size by Type (Diagnostic (SPECT - Technetium, PET- F-18), Therapeutic (Beta Emitters – I-131, Alpha Emitters, Brachytherapy – Y-90)), Application (Oncology, Cardiology) & Region - Global Forecast to 2024
North american nuclear medicine market growth is primed to transition from $2.2 billion in 2019 to $2.7 billion by 2024, showcasing a strong CAGR of 4.1%. Growth in the market can primarily be attributed to factors such as the increasing incidence and prevalence of cancer & cardiac ailments and initiatives to lessen the demand-supply gap of Mo-99. However, the short half-life of radiopharmaceuticals reduces their potential adoption, while hospital budget cuts and high equipment prices are expected to limit market growth to a certain extent.
- Published: January 2020
- Price: $ 4950
- TOC Available:
-
North America Injectable Drug Delivery Market – by Formulations [Liposomes, Microspheres, & Nanoparticles], Devices [Disposables & Reusable, Fillable & Prefilled, Pen, Needle Free & Auto Injectors] & Therapeutics [Diabetes & Oncology] – Forecasts to 2017
The North American injectable drug delivery technologies market was valued at $9.3 billion in 2012; it is expected to reach $16.6 billion by 2017 at a CAGR of 12.3% from 2012 to 2017. Injectable drug delivery technologies are the combination of two major segments; devices and formulations. The North American injectable drug delivery formulations technologies market was the largest segment in this market. In addition, the market is segmented on the basis of its therapeutic applications. In therapeutic area, hormonal disorders command the major segment of injectable drug delivery technologies market due to high demand of injectable in treatment of diabetes. However, auto-immune diseases are the fastest growing segment of this market due to the advent of biologics (tumor necrosis factor (TNF) and Interleukin 1 (IL-1)) and improving patient compliance by the development of self injection devices.
- Published: April 2013
- Price: $ 4950
- TOC Available:
-
3D Scanning Market - By Devices (Optical, Laser, Structured Light), Range (Short , Medium, Large), Solutions (Portable, PCMM), Services (Reverse Engineering, Quality Inspection, Rapid Prototyping) - Worldwide Market Forecasts and Analysis (2013 - 2018)
3D scanning is one of the growing areas of applications amongst the wide range of 3D technologies. This technology is well suited for complex geometries which require high precision.
- Published: July 2013
- Price: $ 4950
- TOC Available:
-
Peracetic Acid Market by Grade (<5% Grade, 5-15% Grade, >15% Grade), Application (Disinfectant, Sterilant, Sanitizer), End-use Industry (Healthcare, Food & Beverage, Water Treatment, Pulp & Paper, Other End-use Industries (Agriculture, Wineries, Breweries, Laundry)), and Region - Global Forecast to 2030
The global peracetic acid market size is projected to reach USD 1.67 billion by 2030 from USD 1.11 billion in 2025 at a CAGR of 8.5% between 2025 and 2030. The key players profiled in the report include Solvay (Belgium), Evonik Industries AG (Germany), Ecolab Inc. (US), MITSUBISHI GAS CHEMICAL COMPANY, INC. (Japan), Enviro Tech Chemical Services (US), Jubilant Life Sciences (Jubilant Pharmova Limited) (India), National Peroxide Limited (India), Kemira OYJ (Finland), Seeler Industries Inc. (US), and Airedale Chemical (UK), among others.
- Published: July 2025
- Price: $ 4950
- TOC Available:
-
Cloud Database and DBaaS Market by Database Type (SQL and NoSQL), Component (Solutions & Services), Deployment Mode, Organization Size, Vertical (BFSI, IT & Telecom, Manufacturing, Healthcare & Life Sciences) and Region - Global Forecast to 2028
The global Cloud Database and DBaaS market size is projected to reach USD 57.5 billion by 2028 at a Compound Annual Growth Rate (CAGR) of 22.0% during the forecast period. Some prominent players across all service types profiled in the Cloud Database and DBaaS market study include Google (US), Microsoft (US), AWS (US), IBM (US), Oraclev (US), Alibaba Cloud (China), SAP (Germany), MongoDB (US), EnterpriseDB (US), Redis Labs (US), Tencent (China), Rackspace (US), Teradata (US), CenturyLink (US), Neo4J (US), Datastax (US), Tigergraph (US), MariaDB (US), RDX (US), SingleStore (US).
- Published: July 2023
- Price: $ 4950
- TOC Available:
-
Propanol Market by Type (N-Propanol, Isopropanol), Application (Direct Solvent, Chemical Intermediate, Pharmaceutical, Household & Personal Care), and Region (North America, APAC, Europe, Middle East & Africa, and South America) - Global Forecast to 2023
The propanol market size is estimated at USD 3.5 billion in 2018 and is projected to reach USD 4.2 billion by 2023, at a CAGR of 4.0%. The propanol market is majorly driven by the household & personal care and pharmaceutical applications in APAC, mainly from India, China, Japan, South Korea, and Southeast Asian countries. Royal Dutch Shell Plc (Netherlands), Exxon Mobil Corporation (US), BASF SE (Germany), The Dow Chemical Company (US), LG Chem Ltd. (South Korea), Sasol Limited (South Africa), Eastman Chemical Company (US), Tokuyama Corporation (Japan), LCY Chemical Corp. (Taiwan), JXTG Holdings, Inc. (Japan), Deepak Fertilisers and Petrochemicals Corporation Ltd. (India), and OXEA GmbH (Germany)
- Published: April 2019
- Price: $ 4950
- TOC Available:
-
Torque Sensor Market Size, Share & Industry Growth Analysis Report by Type (Rotary Torque Sensors and Reaction Torque Sensors), Application (Automotive, Test & Measurement, Industrial, Aerospace & Defense), Technology, and Geography- Global Growth Driver and Industry Forecast to 2035
The global torque sensor market is witnessing steady expansion, driven by increasing adoption across automotive, industrial automation, and aerospace sectors. In 2025, the market is estimated to be valued at approximately USD 8.2 - 8.6 billion and is projected to reach nearly USD 15.6 - 17.2billion by 2035, growing at a compound annual growth rate (CAGR) of around 6.7% - 7.1% during the forecast period. The growth trajectory is strongly influenced by the rising integration of AI-powered monitoring systems, IoT-enabled smart manufacturing, and the broader shift toward digital transformation across industries. Torque sensors are becoming critical components in precision control systems, enabling real-time data analytics, predictive maintenance, and improved operational efficiency in automated environments.
- Published: November 2026
- Price: $ 4950
- TOC Available:
Records 1 to 10 of 50
